nodes	percent_of_prediction	percent_of_DWPC	metapath
Morphine—UGT1A1—urine—nephrolithiasis	0.0395	0.196	CbGeAlD
Morphine—UGT1A8—renal system—nephrolithiasis	0.0222	0.11	CbGeAlD
Morphine—UGT1A8—kidney—nephrolithiasis	0.0215	0.107	CbGeAlD
Morphine—Anorectal disorder—Hydrochlorothiazide—nephrolithiasis	0.0185	0.0336	CcSEcCtD
Morphine—Sleep disturbance—Hydrochlorothiazide—nephrolithiasis	0.0173	0.0315	CcSEcCtD
Morphine—UGT1A8—Phase II conjugation—SLC26A1—nephrolithiasis	0.0149	0.0599	CbGpPWpGaD
Morphine—UGT2B15—Phase II conjugation—SLC26A1—nephrolithiasis	0.013	0.0524	CbGpPWpGaD
Morphine—UGT2B4—Phase II conjugation—SLC26A1—nephrolithiasis	0.013	0.0524	CbGpPWpGaD
Morphine—CYP3A4—urine—nephrolithiasis	0.0127	0.0628	CbGeAlD
Morphine—CYP2D6—urine—nephrolithiasis	0.0125	0.0618	CbGeAlD
Morphine—UGT2B7—renal system—nephrolithiasis	0.0114	0.0564	CbGeAlD
Morphine—OPRD1—renal system—nephrolithiasis	0.0111	0.0553	CbGeAlD
Morphine—UGT2B7—kidney—nephrolithiasis	0.011	0.0545	CbGeAlD
Morphine—Rhabdomyolysis—Hydrochlorothiazide—nephrolithiasis	0.011	0.0199	CcSEcCtD
Morphine—OPRD1—kidney—nephrolithiasis	0.0108	0.0535	CbGeAlD
Morphine—Gastrooesophageal reflux disease—Hydrochlorothiazide—nephrolithiasis	0.0107	0.0195	CcSEcCtD
Morphine—Bone pain—Hydrochlorothiazide—nephrolithiasis	0.0101	0.0184	CcSEcCtD
Morphine—Coordination abnormal—Hydrochlorothiazide—nephrolithiasis	0.00988	0.018	CcSEcCtD
Morphine—Ventricular tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00971	0.0176	CcSEcCtD
Morphine—UGT1A1—renal system—nephrolithiasis	0.00966	0.048	CbGeAlD
Morphine—Wheezing—Hydrochlorothiazide—nephrolithiasis	0.00943	0.0171	CcSEcCtD
Morphine—UGT1A1—kidney—nephrolithiasis	0.00934	0.0464	CbGeAlD
Morphine—OPRL1—G alpha (i) signalling events—RGS14—nephrolithiasis	0.00895	0.036	CbGpPWpGaD
Morphine—UGT1A8—Biological oxidations—SLC26A1—nephrolithiasis	0.00871	0.035	CbGpPWpGaD
Morphine—Pulmonary oedema—Hydrochlorothiazide—nephrolithiasis	0.00864	0.0157	CcSEcCtD
Morphine—Sleep disorder—Hydrochlorothiazide—nephrolithiasis	0.00814	0.0148	CcSEcCtD
Morphine—Polyuria—Hydrochlorothiazide—nephrolithiasis	0.00802	0.0146	CcSEcCtD
Morphine—Swelling—Hydrochlorothiazide—nephrolithiasis	0.00799	0.0145	CcSEcCtD
Morphine—Gastroenteritis—Hydrochlorothiazide—nephrolithiasis	0.00795	0.0144	CcSEcCtD
Morphine—Haemolytic anaemia—Hydrochlorothiazide—nephrolithiasis	0.0078	0.0142	CcSEcCtD
Morphine—Injury—Hydrochlorothiazide—nephrolithiasis	0.00767	0.0139	CcSEcCtD
Morphine—UGT2B15—Biological oxidations—SLC26A1—nephrolithiasis	0.00761	0.0306	CbGpPWpGaD
Morphine—UGT2B4—Biological oxidations—SLC26A1—nephrolithiasis	0.00761	0.0306	CbGpPWpGaD
Morphine—Libido decreased—Hydrochlorothiazide—nephrolithiasis	0.0076	0.0138	CcSEcCtD
Morphine—Atrial fibrillation—Hydrochlorothiazide—nephrolithiasis	0.00744	0.0135	CcSEcCtD
Morphine—Visual disturbance—Hydrochlorothiazide—nephrolithiasis	0.00744	0.0135	CcSEcCtD
Morphine—Renal impairment—Hydrochlorothiazide—nephrolithiasis	0.0074	0.0135	CcSEcCtD
Morphine—Thirst—Hydrochlorothiazide—nephrolithiasis	0.0074	0.0135	CcSEcCtD
Morphine—Hyponatraemia—Hydrochlorothiazide—nephrolithiasis	0.00707	0.0129	CcSEcCtD
Morphine—Disturbance in sexual arousal—Hydrochlorothiazide—nephrolithiasis	0.00699	0.0127	CcSEcCtD
Morphine—UGT1A3—Phase II conjugation—SLC26A1—nephrolithiasis	0.00697	0.0281	CbGpPWpGaD
Morphine—Affect lability—Hydrochlorothiazide—nephrolithiasis	0.00694	0.0126	CcSEcCtD
Morphine—Mood swings—Hydrochlorothiazide—nephrolithiasis	0.00668	0.0121	CcSEcCtD
Morphine—Ataxia—Hydrochlorothiazide—nephrolithiasis	0.00663	0.012	CcSEcCtD
Morphine—Liver function test abnormal—Hydrochlorothiazide—nephrolithiasis	0.00651	0.0118	CcSEcCtD
Morphine—Dry skin—Hydrochlorothiazide—nephrolithiasis	0.00646	0.0117	CcSEcCtD
Morphine—Orthostatic hypotension—Hydrochlorothiazide—nephrolithiasis	0.00644	0.0117	CcSEcCtD
Morphine—Abdominal pain upper—Hydrochlorothiazide—nephrolithiasis	0.00644	0.0117	CcSEcCtD
Morphine—Hypokalaemia—Hydrochlorothiazide—nephrolithiasis	0.00641	0.0117	CcSEcCtD
Morphine—Breast disorder—Hydrochlorothiazide—nephrolithiasis	0.00637	0.0116	CcSEcCtD
Morphine—Cramp muscle—Hydrochlorothiazide—nephrolithiasis	0.00635	0.0115	CcSEcCtD
Morphine—Abdominal distension—Hydrochlorothiazide—nephrolithiasis	0.00613	0.0111	CcSEcCtD
Morphine—Dysphagia—Hydrochlorothiazide—nephrolithiasis	0.00609	0.0111	CcSEcCtD
Morphine—Influenza—Hydrochlorothiazide—nephrolithiasis	0.00609	0.0111	CcSEcCtD
Morphine—UGT2B7—Phase II conjugation—SLC26A1—nephrolithiasis	0.00593	0.0239	CbGpPWpGaD
Morphine—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.00569	0.0104	CcSEcCtD
Morphine—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.00561	0.0102	CcSEcCtD
Morphine—Hyperglycaemia—Hydrochlorothiazide—nephrolithiasis	0.00549	0.00999	CcSEcCtD
Morphine—Renal failure—Hydrochlorothiazide—nephrolithiasis	0.00534	0.0097	CcSEcCtD
Morphine—Urinary tract infection—Hydrochlorothiazide—nephrolithiasis	0.00528	0.00959	CcSEcCtD
Morphine—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.00528	0.00959	CcSEcCtD
Morphine—Sweating—Hydrochlorothiazide—nephrolithiasis	0.00521	0.00946	CcSEcCtD
Morphine—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.00496	0.00902	CcSEcCtD
Morphine—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.00489	0.00888	CcSEcCtD
Morphine—Hepatitis—Hydrochlorothiazide—nephrolithiasis	0.00487	0.00886	CcSEcCtD
Morphine—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.00485	0.00882	CcSEcCtD
Morphine—UGT1A1—Phase II conjugation—SLC26A1—nephrolithiasis	0.00482	0.0194	CbGpPWpGaD
Morphine—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.0048	0.00873	CcSEcCtD
Morphine—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.0047	0.00854	CcSEcCtD
Morphine—UGT1A3—NRF2 pathway—SLC2A9—nephrolithiasis	0.00465	0.0187	CbGpPWpGaD
Morphine—CYP2C8—renal system—nephrolithiasis	0.00457	0.0227	CbGeAlD
Morphine—Flushing—Hydrochlorothiazide—nephrolithiasis	0.00452	0.00822	CcSEcCtD
Morphine—CYP2C8—kidney—nephrolithiasis	0.00442	0.0219	CbGeAlD
Morphine—Erythema—Hydrochlorothiazide—nephrolithiasis	0.00424	0.00771	CcSEcCtD
Morphine—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.00418	0.0076	CcSEcCtD
Morphine—Tension—Hydrochlorothiazide—nephrolithiasis	0.00416	0.00757	CcSEcCtD
Morphine—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.00416	0.00755	CcSEcCtD
Morphine—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.00412	0.00749	CcSEcCtD
Morphine—Back pain—Hydrochlorothiazide—nephrolithiasis	0.0041	0.00746	CcSEcCtD
Morphine—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.00408	0.00742	CcSEcCtD
Morphine—UGT1A3—Biological oxidations—SLC26A1—nephrolithiasis	0.00408	0.0164	CbGpPWpGaD
Morphine—OPRL1—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00406	0.0163	CbGpPWpGaD
Morphine—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.004	0.00727	CcSEcCtD
Morphine—Tremor—Hydrochlorothiazide—nephrolithiasis	0.00398	0.00723	CcSEcCtD
Morphine—UGT2B7—NRF2 pathway—SLC2A9—nephrolithiasis	0.00395	0.0159	CbGpPWpGaD
Morphine—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00394	0.00716	CcSEcCtD
Morphine—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.00392	0.00713	CcSEcCtD
Morphine—Agitation—Hydrochlorothiazide—nephrolithiasis	0.0039	0.00709	CcSEcCtD
Morphine—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00383	0.00696	CcSEcCtD
Morphine—OPRD1—G alpha (i) signalling events—RGS14—nephrolithiasis	0.00382	0.0154	CbGpPWpGaD
Morphine—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.00381	0.00693	CcSEcCtD
Morphine—Syncope—Hydrochlorothiazide—nephrolithiasis	0.00381	0.00692	CcSEcCtD
Morphine—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.0038	0.0069	CcSEcCtD
Morphine—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00375	0.00682	CcSEcCtD
Morphine—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00373	0.00678	CcSEcCtD
Morphine—Cough—Hydrochlorothiazide—nephrolithiasis	0.0037	0.00673	CcSEcCtD
Morphine—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00361	0.00657	CcSEcCtD
Morphine—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00361	0.00657	CcSEcCtD
Morphine—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.0036	0.00654	CcSEcCtD
Morphine—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00357	0.00649	CcSEcCtD
Morphine—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00353	0.00642	CcSEcCtD
Morphine—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00349	0.00635	CcSEcCtD
Morphine—OPRL1—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00348	0.014	CbGpPWpGaD
Morphine—UGT2B7—Biological oxidations—SLC26A1—nephrolithiasis	0.00347	0.014	CbGpPWpGaD
Morphine—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.00346	0.00629	CcSEcCtD
Morphine—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00346	0.00629	CcSEcCtD
Morphine—Shock—Hydrochlorothiazide—nephrolithiasis	0.00341	0.00619	CcSEcCtD
Morphine—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00339	0.00616	CcSEcCtD
Morphine—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00338	0.00614	CcSEcCtD
Morphine—OPRK1—G alpha (i) signalling events—RGS14—nephrolithiasis	0.00335	0.0135	CbGpPWpGaD
Morphine—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00335	0.00609	CcSEcCtD
Morphine—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.0033	0.006	CcSEcCtD
Morphine—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00324	0.00588	CcSEcCtD
Morphine—UGT1A1—NRF2 pathway—SLC2A9—nephrolithiasis	0.00321	0.0129	CbGpPWpGaD
Morphine—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00316	0.00573	CcSEcCtD
Morphine—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00313	0.00569	CcSEcCtD
Morphine—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00311	0.00565	CcSEcCtD
Morphine—CYP3A4—renal system—nephrolithiasis	0.0031	0.0154	CbGeAlD
Morphine—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00309	0.00561	CcSEcCtD
Morphine—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00308	0.0056	CcSEcCtD
Morphine—OPRL1—GPCR downstream signaling—RGS14—nephrolithiasis	0.00306	0.0123	CbGpPWpGaD
Morphine—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00305	0.00554	CcSEcCtD
Morphine—CYP2D6—renal system—nephrolithiasis	0.00305	0.0151	CbGeAlD
Morphine—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00301	0.00547	CcSEcCtD
Morphine—CYP3A4—kidney—nephrolithiasis	0.00299	0.0149	CbGeAlD
Morphine—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00299	0.00543	CcSEcCtD
Morphine—Pain—Hydrochlorothiazide—nephrolithiasis	0.00296	0.00538	CcSEcCtD
Morphine—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00296	0.00538	CcSEcCtD
Morphine—CYP2D6—kidney—nephrolithiasis	0.00294	0.0146	CbGeAlD
Morphine—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00285	0.00519	CcSEcCtD
Morphine—OPRM1—G alpha (i) signalling events—RGS14—nephrolithiasis	0.00283	0.0114	CbGpPWpGaD
Morphine—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00283	0.00515	CcSEcCtD
Morphine—UGT1A1—Biological oxidations—SLC26A1—nephrolithiasis	0.00282	0.0113	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—RGS14—nephrolithiasis	0.00278	0.0112	CbGpPWpGaD
Morphine—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00275	0.005	CcSEcCtD
Morphine—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00274	0.00498	CcSEcCtD
Morphine—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00274	0.00498	CcSEcCtD
Morphine—OPRL1—GPCR ligand binding—CHRM3—nephrolithiasis	0.00265	0.0107	CbGpPWpGaD
Morphine—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00255	0.00464	CcSEcCtD
Morphine—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00248	0.00452	CcSEcCtD
Morphine—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00245	0.00445	CcSEcCtD
Morphine—OPRL1—GPCR ligand binding—PTH—nephrolithiasis	0.00242	0.00974	CbGpPWpGaD
Morphine—ABCB1—nephron tubule—nephrolithiasis	0.00241	0.012	CbGeAlD
Morphine—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00237	0.00431	CcSEcCtD
Morphine—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00229	0.00416	CcSEcCtD
Morphine—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.0022	0.004	CcSEcCtD
Morphine—ABCB1—renal system—nephrolithiasis	0.00219	0.0109	CbGeAlD
Morphine—Rash—Hydrochlorothiazide—nephrolithiasis	0.00218	0.00397	CcSEcCtD
Morphine—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00218	0.00397	CcSEcCtD
Morphine—Headache—Hydrochlorothiazide—nephrolithiasis	0.00217	0.00394	CcSEcCtD
Morphine—ABCB1—kidney—nephrolithiasis	0.00212	0.0105	CbGeAlD
Morphine—OPRL1—GPCR downstream signaling—DGKH—nephrolithiasis	0.00207	0.00833	CbGpPWpGaD
Morphine—ABCB1—cortex of kidney—nephrolithiasis	0.00206	0.0102	CbGeAlD
Morphine—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00206	0.00374	CcSEcCtD
Morphine—UGT1A8—Metabolism—GRHPR—nephrolithiasis	0.00197	0.00791	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—ADCY10—nephrolithiasis	0.00193	0.00778	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—DGKH—nephrolithiasis	0.00188	0.00756	CbGpPWpGaD
Morphine—UGT1A8—Metabolism—AGXT—nephrolithiasis	0.00175	0.00705	CbGpPWpGaD
Morphine—OPRD1—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00173	0.00697	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—GRHPR—nephrolithiasis	0.00172	0.00691	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—GRHPR—nephrolithiasis	0.00172	0.00691	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—RGS14—nephrolithiasis	0.00164	0.00661	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—AGXT—nephrolithiasis	0.00153	0.00616	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—AGXT—nephrolithiasis	0.00153	0.00616	CbGpPWpGaD
Morphine—OPRK1—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00152	0.00611	CbGpPWpGaD
Morphine—OPRL1—GPCR downstream signaling—CHRM3—nephrolithiasis	0.0015	0.00602	CbGpPWpGaD
Morphine—UGT1A8—Metabolism—APRT—nephrolithiasis	0.00149	0.00599	CbGpPWpGaD
Morphine—UGT1A8—Metabolism—SLC26A1—nephrolithiasis	0.00149	0.00599	CbGpPWpGaD
Morphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00148	0.00597	CbGpPWpGaD
Morphine—CYP2C8—Biological oxidations—SLC26A1—nephrolithiasis	0.00148	0.00597	CbGpPWpGaD
Morphine—OPRL1—GPCR downstream signaling—PTH—nephrolithiasis	0.00137	0.00551	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—CHRM3—nephrolithiasis	0.00136	0.00547	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—RGS14—nephrolithiasis	0.00131	0.00526	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—APRT—nephrolithiasis	0.0013	0.00524	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—APRT—nephrolithiasis	0.0013	0.00524	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—SLC26A1—nephrolithiasis	0.0013	0.00524	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—SLC26A1—nephrolithiasis	0.0013	0.00524	CbGpPWpGaD
Morphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.0013	0.00524	CbGpPWpGaD
Morphine—OPRM1—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00128	0.00517	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—PTH—nephrolithiasis	0.00124	0.005	CbGpPWpGaD
Morphine—CYP2D6—Biological oxidations—SLC26A1—nephrolithiasis	0.00122	0.0049	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—RGS14—nephrolithiasis	0.00119	0.00478	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—RGS14—nephrolithiasis	0.00115	0.00461	CbGpPWpGaD
Morphine—OPRD1—GPCR ligand binding—CHRM3—nephrolithiasis	0.00113	0.00455	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00111	0.00447	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—DGKH—nephrolithiasis	0.00111	0.00447	CbGpPWpGaD
Morphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.0011	0.00443	CbGpPWpGaD
Morphine—UGT1A8—Metabolism—AQP1—nephrolithiasis	0.00106	0.00427	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—RGS14—nephrolithiasis	0.00104	0.00419	CbGpPWpGaD
Morphine—OPRD1—GPCR ligand binding—PTH—nephrolithiasis	0.00103	0.00416	CbGpPWpGaD
Morphine—OPRK1—GPCR ligand binding—CHRM3—nephrolithiasis	0.000991	0.00399	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—RGS14—nephrolithiasis	0.000969	0.0039	CbGpPWpGaD
Morphine—UGT1A8—Metabolism—CHRM3—nephrolithiasis	0.00096	0.00386	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—AQP1—nephrolithiasis	0.000928	0.00373	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—AQP1—nephrolithiasis	0.000928	0.00373	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—GRHPR—nephrolithiasis	0.00092	0.0037	CbGpPWpGaD
Morphine—OPRK1—GPCR ligand binding—PTH—nephrolithiasis	0.000906	0.00365	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—DGKH—nephrolithiasis	0.000883	0.00355	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—RGS14—nephrolithiasis	0.00088	0.00354	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—CHRM3—nephrolithiasis	0.000839	0.00338	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—CHRM3—nephrolithiasis	0.000839	0.00338	CbGpPWpGaD
Morphine—OPRM1—GPCR ligand binding—CHRM3—nephrolithiasis	0.000837	0.00337	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—ADCY10—nephrolithiasis	0.000825	0.00332	CbGpPWpGaD
Morphine—ABCB1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000822	0.00331	CbGpPWpGaD
Morphine—ABCB1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000822	0.00331	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—AGXT—nephrolithiasis	0.00082	0.0033	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—CHRM3—nephrolithiasis	0.000802	0.00323	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—DGKH—nephrolithiasis	0.000802	0.00323	CbGpPWpGaD
Morphine—CYP3A4—Biological oxidations—SLC26A1—nephrolithiasis	0.000796	0.0032	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—GRHPR—nephrolithiasis	0.000782	0.00315	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—DGKH—nephrolithiasis	0.000774	0.00312	CbGpPWpGaD
Morphine—OPRM1—GPCR ligand binding—PTH—nephrolithiasis	0.000766	0.00308	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—PTH—nephrolithiasis	0.000734	0.00295	CbGpPWpGaD
Morphine—ABCB1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000732	0.00295	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—ADCY10—nephrolithiasis	0.000723	0.00291	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—DGKH—nephrolithiasis	0.000703	0.00283	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—RGS14—nephrolithiasis	0.000701	0.00282	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—SLC26A1—nephrolithiasis	0.000697	0.00281	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—APRT—nephrolithiasis	0.000697	0.00281	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—AGXT—nephrolithiasis	0.000697	0.00281	CbGpPWpGaD
Morphine—ABCB1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00067	0.0027	CbGpPWpGaD
Morphine—ABCB1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00067	0.0027	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—DGKH—nephrolithiasis	0.000655	0.00263	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000639	0.00257	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—GRHPR—nephrolithiasis	0.000636	0.00256	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—RGS14—nephrolithiasis	0.000615	0.00248	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—ADCY10—nephrolithiasis	0.000611	0.00246	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—DGKH—nephrolithiasis	0.000594	0.00239	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—SLC26A1—nephrolithiasis	0.000593	0.00239	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—APRT—nephrolithiasis	0.000593	0.00239	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—PTH—nephrolithiasis	0.000584	0.00235	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—CHRM3—nephrolithiasis	0.00058	0.00233	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—AGXT—nephrolithiasis	0.000567	0.00228	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00056	0.00225	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—PTH—nephrolithiasis	0.00053	0.00213	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—RGS14—nephrolithiasis	0.00052	0.00209	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—PTH—nephrolithiasis	0.000512	0.00206	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—CHRM3—nephrolithiasis	0.000508	0.00205	CbGpPWpGaD
Morphine—ABCB1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000508	0.00204	CbGpPWpGaD
Morphine—ABCB1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000508	0.00204	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—AQP1—nephrolithiasis	0.000497	0.002	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—SLC26A1—nephrolithiasis	0.000482	0.00194	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—APRT—nephrolithiasis	0.000482	0.00194	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000474	0.00191	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—DGKH—nephrolithiasis	0.000474	0.00191	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000473	0.0019	CbGpPWpGaD
Morphine—ABCB1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000472	0.0019	CbGpPWpGaD
Morphine—ABCB1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000472	0.0019	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—PTH—nephrolithiasis	0.000465	0.00187	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—CHRM3—nephrolithiasis	0.000449	0.00181	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—PTH—nephrolithiasis	0.000433	0.00174	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—CHRM3—nephrolithiasis	0.00043	0.00173	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—AQP1—nephrolithiasis	0.000422	0.0017	CbGpPWpGaD
Morphine—ABCB1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000421	0.00169	CbGpPWpGaD
Morphine—ABCB1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000421	0.00169	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000415	0.00167	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—DGKH—nephrolithiasis	0.000415	0.00167	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—PTH—nephrolithiasis	0.000393	0.00158	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—CHRM3—nephrolithiasis	0.000382	0.00154	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—SPP1—nephrolithiasis	0.000368	0.00148	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000351	0.00141	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—DGKH—nephrolithiasis	0.000351	0.00141	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—AQP1—nephrolithiasis	0.000343	0.00138	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CHRM3—nephrolithiasis	0.000343	0.00138	CbGpPWpGaD
Morphine—ABCB1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000336	0.00135	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—GRHPR—nephrolithiasis	0.000335	0.00135	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—PTH—nephrolithiasis	0.000313	0.00126	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—CHRM3—nephrolithiasis	0.00031	0.00125	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CHRM3—nephrolithiasis	0.0003	0.00121	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—AGXT—nephrolithiasis	0.000298	0.0012	CbGpPWpGaD
Morphine—ABCB1—Metabolism—GRHPR—nephrolithiasis	0.000292	0.00117	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—GRHPR—nephrolithiasis	0.000275	0.00111	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—PTH—nephrolithiasis	0.000275	0.00111	CbGpPWpGaD
Morphine—ABCB1—Metabolism—AGXT—nephrolithiasis	0.00026	0.00105	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CHRM3—nephrolithiasis	0.000254	0.00102	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—APRT—nephrolithiasis	0.000254	0.00102	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—SLC26A1—nephrolithiasis	0.000254	0.00102	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—AGXT—nephrolithiasis	0.000245	0.000986	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—PTH—nephrolithiasis	0.000232	0.000934	CbGpPWpGaD
Morphine—ABCB1—Metabolism—SLC26A1—nephrolithiasis	0.000221	0.00089	CbGpPWpGaD
Morphine—ABCB1—Metabolism—APRT—nephrolithiasis	0.000221	0.00089	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—SLC26A1—nephrolithiasis	0.000208	0.000838	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—APRT—nephrolithiasis	0.000208	0.000838	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—AQP1—nephrolithiasis	0.000181	0.000728	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—GRHPR—nephrolithiasis	0.00018	0.000723	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—CHRM3—nephrolithiasis	0.000163	0.000658	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—AGXT—nephrolithiasis	0.00016	0.000645	CbGpPWpGaD
Morphine—ABCB1—Metabolism—AQP1—nephrolithiasis	0.000157	0.000634	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—SPP1—nephrolithiasis	0.000157	0.000633	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—AQP1—nephrolithiasis	0.000148	0.000597	CbGpPWpGaD
Morphine—ABCB1—Metabolism—CHRM3—nephrolithiasis	0.000142	0.000573	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—SPP1—nephrolithiasis	0.000138	0.000555	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—APRT—nephrolithiasis	0.000136	0.000548	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—SLC26A1—nephrolithiasis	0.000136	0.000548	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—CHRM3—nephrolithiasis	0.000134	0.00054	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—SPP1—nephrolithiasis	0.000117	0.000469	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—AQP1—nephrolithiasis	9.7e-05	0.000391	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CHRM3—nephrolithiasis	8.77e-05	0.000353	CbGpPWpGaD
